Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcripts of the webcasts will be ...
Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, 2025. The Zacks Consensus Estimate for fourth-quarter revenues is pegged ...
Analyst Chris Schott from J.P. Morgan maintained a Buy rating on Regeneron (REGN – Research Report) and keeping the price target at $1,100.00. Chris Schott has given his Buy rating due to a ...
Regeneron Pharmaceuticals, Inc. (REGN) Securities Class Action: The litigation is focused on the propriety of Regeneron’s statements about its compliance with applicable rules and regulations ...
Copyright 2025 The Associated Press. All Rights Reserved. Fianna Fail leader Micheal Martin, right, and Fine Gael’s Simon Harris talk to the media outside the ...
Ireland has delayed choosing its new prime minister after a row over speaking rights sparked angry scenes in parliament. The Irish Parliament, called the Dail, had this morning convened to ...
SAN FRANCISCO — Just over 20 years ago, the people of California voted to spend billions of dollars on an exciting new idea to remake medicine … ...
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) of a class action securities ...
Ireland should brace itself for storm force winds, heavy rain, sleet and snow, beginning on Thursday night when Storm Éowyn makes landfall. Met Éireann has issued an advisory for strong to gale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results